150 related articles for article (PubMed ID: 24825067)
1. JK1 (FAM134B) gene and colorectal cancer: a pilot study on the gene copy number alterations and correlations with clinicopathological parameters.
Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
Exp Mol Pathol; 2014 Aug; 97(1):31-6. PubMed ID: 24825067
[TBL] [Abstract][Full Text] [Related]
2. The roles of JK-1 (FAM134B) expressions in colorectal cancer.
Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
Exp Cell Res; 2014 Aug; 326(1):166-73. PubMed ID: 24973512
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer.
Islam F; Gopalan V; Pillai S; Lu CT; Kasem K; Lam AK
Genes Chromosomes Cancer; 2018 May; 57(5):240-251. PubMed ID: 29318692
[TBL] [Abstract][Full Text] [Related]
4. GAEC1 and colorectal cancer: a study of the relationships between a novel oncogene and clinicopathologic features.
Gopalan V; Smith RA; Nassiri MR; Yasuda K; Salajegheh A; Kim SY; Ho YH; Weinstein S; Tang JC; Lam AK
Hum Pathol; 2010 Jul; 41(7):1009-15. PubMed ID: 20236690
[TBL] [Abstract][Full Text] [Related]
5. Altered JS-2 expression in colorectal cancers and its clinical pathological relevance.
Lam AK; Gopalan V; Nassiri MR; Kasim K; Dissanayake J; Tang JC; Smith RA
Mol Oncol; 2011 Oct; 5(5):475-81. PubMed ID: 21802380
[TBL] [Abstract][Full Text] [Related]
6. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
Alqurashi N; Gopalan V; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
[TBL] [Abstract][Full Text] [Related]
7. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK
Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195
[TBL] [Abstract][Full Text] [Related]
8. Novel FAM134B mutations and their clinicopathological significance in colorectal cancer.
Islam F; Gopalan V; Wahab R; Lee KT; Haque MH; Mamoori A; Lu CT; Smith RA; Lam AK
Hum Genet; 2017 Mar; 136(3):321-337. PubMed ID: 28144752
[TBL] [Abstract][Full Text] [Related]
9. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
[TBL] [Abstract][Full Text] [Related]
10. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
Sillars-Hardebol AH; Carvalho B; Tijssen M; Beliën JA; de Wit M; Delis-van Diemen PM; Pontén F; van de Wiel MA; Fijneman RJ; Meijer GA
Gut; 2012 Nov; 61(11):1568-75. PubMed ID: 22207630
[TBL] [Abstract][Full Text] [Related]
11. Detection of APC gene deletions in colorectal malignancies using quantitative PCR in a Chinese population.
Fang Z; Xiong Y; Li J; Liu L; Li M; Zhang W; Shi L; Wan J
Pathol Oncol Res; 2011 Sep; 17(3):657-61. PubMed ID: 21359685
[TBL] [Abstract][Full Text] [Related]
12. Molecular alterations in colorectal adenomas and intramucosal adenocarcinomas defined by high-density single-nucleotide polymorphism arrays.
Eizuka M; Sugai T; Habano W; Uesugi N; Takahashi Y; Kawasaki K; Yamamoto E; Suzuki H; Matsumoto T
J Gastroenterol; 2017 Nov; 52(11):1158-1168. PubMed ID: 28197804
[TBL] [Abstract][Full Text] [Related]
13. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
Zhang X; Wang Y; Gao N; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial DNA copy number in colorectal cancer: between tissue comparisons, clinicopathological characteristics and survival.
van Osch FH; Voets AM; Schouten LJ; Gottschalk RW; Simons CC; van Engeland M; Lentjes MH; van den Brandt PA; Smeets HJ; Weijenberg MP
Carcinogenesis; 2015 Dec; 36(12):1502-10. PubMed ID: 26476438
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathological significance of REIC expression in colorectal carcinomas.
Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
[TBL] [Abstract][Full Text] [Related]
16. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
[TBL] [Abstract][Full Text] [Related]
17. Consensus molecular subtype classification of colorectal adenomas.
Komor MA; Bosch LJ; Bounova G; Bolijn AS; Delis-van Diemen PM; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; van Grieken NC; Carvalho B; Wessels LF; Jimenez CR; Fijneman RJ; Meijer GA;
J Pathol; 2018 Nov; 246(3):266-276. PubMed ID: 29968252
[TBL] [Abstract][Full Text] [Related]
18. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
Meng H; Li W; Boardman LA; Wang L
BMC Cancer; 2018 Apr; 18(1):433. PubMed ID: 29661177
[TBL] [Abstract][Full Text] [Related]
19. Reduced rate of copy number aberrations in mucinous colorectal carcinoma.
Hugen N; Simmer F; Mekenkamp LJ; Koopman M; van den Broek E; de Wilt JH; Punt CJ; Ylstra B; Meijer GA; Nagtegaal ID
Oncotarget; 2015 Sep; 6(28):25715-25. PubMed ID: 26329972
[TBL] [Abstract][Full Text] [Related]
20. Colorectal carcinoma associated with serrated adenoma--prevalence, histological features, and prognosis.
Mäkinen MJ; George SM; Jernvall P; Mäkelä J; Vihko P; Karttunen TJ
J Pathol; 2001 Mar; 193(3):286-94. PubMed ID: 11241406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
